|
COQ2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.08300000000317E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62589999999074E-05 |
| Normal-vs-Stage2 |
6.688400E-02 |
| Normal-vs-Stage3 |
1.396490E-02 |
| Normal-vs-Stage4 |
2.552100E-02 |
| Stage1-vs-Stage2 |
1.901380E-01 |
| Stage1-vs-Stage3 |
4.187800E-02 |
| Stage1-vs-Stage4 |
1.320400E-01 |
| Stage2-vs-Stage3 |
9.826400E-01 |
| Stage2-vs-Stage4 |
9.351200E-01 |
| Stage3-vs-Stage4 |
9.338600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.32959999999705E-05 |
| Normal-vs-AfricanAmerican |
2.965400E-01 |
| Normal-vs-Asian |
6.760400E-04 |
| Caucasian-vs-AfricanAmerican |
4.850500E-02 |
| Caucasian-vs-Asian |
6.817400E-01 |
| AfricanAmerican-vs-Asian |
6.700100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.87099999999463E-05 |
| Normal-vs-Female |
3.199800E-04 |
| Male-vs-Female |
2.192000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.85139999999895E-05 |
| Normal-vs-Age(41-60Yrs) |
5.795600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.566360E-02 |
| Normal-vs-Age(81-100Yrs) |
2.938000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.440100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.201570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.604370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.917400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.861600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.643600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.348000E-01 |
| Classical-VS-Follicular |
1.003370E-04 |
| Classical-VS-Other |
5.874800E-01 |
| Classical-VS-Normal |
1.47679999995542E-06 |
| Tall-VS-Follicular |
4.156400E-02 |
| Tall-VS-Other |
7.268800E-01 |
| Tall-VS-Normal |
3.521500E-03 |
| Follicular-VS-Other |
4.475800E-01 |
| Follicular-VS-Normal |
4.450000E-01 |
| Other-VS-Normal |
2.045200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.104000E-03 |
| Normal-vs-N1 |
1.411500E-02 |
| N0-vs-N1 |
4.447000E-01 |
|
|
